Jazz Pharmaceuticals (JAZZ) Current Taxes (2012 - 2026)

Jazz Pharmaceuticals' Current Taxes history runs 15 years deep, the most recent figure standing at $93.7 million for Q1 2026.

• In Q1 2026, Current Taxes rose 195.01% year-over-year to $93.7 million; the TTM figure through Mar 2026 stood at $93.7 million (up 195.01% YoY), while the FY2025 annual figure was $56.3 million, up 200.15% from the prior year.
• Current Taxes was $93.7 million for Q1 2026 at Jazz Pharmaceuticals, up from $56.3 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $93.7 million in Q1 2026 to a low of $5.8 million in Q2 2022.
• Historically, Current Taxes has averaged $47.6 million across 5 years, with a median of $49.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Taxes tumbled 69.51% in 2022, then soared 1065.1% in 2023.
• A 5-year view of Current Taxes shows it stood at $7.7 million in 2022, then jumped by 354.5% to $35.1 million in 2023, then slumped by 46.52% to $18.8 million in 2024, then soared by 200.15% to $56.3 million in 2025, then soared by 66.43% to $93.7 million in 2026.
• The last three Current Taxes figures came in at $93.7 million (Q1 2026), $56.3 million (Q4 2025), and $91.1 million (Q3 2025), per Business Quant data.